MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 461 to 480 of 166,322 approvalsPage 24 of 8317

Compound Sodium Acetate and Glucose Injection

Approval Number: 国药准字H20254144
Registration: May 13, 2025

Fluvoxamine Maleate Tablets

Approval Number: 国药准字H20254177
Registration: May 13, 2025

Metaraminol Bitartrate Injection

Approval Number: 国药准字H20254183
Registration: May 13, 2025

Neostigmine Methylsulfate Injection

Approval Number: 国药准字H20254179
Registration: May 13, 2025

Tenecteplase for Injection

Approval Number: 国药准字SJ20250017
Registration: May 13, 2025

Vardenafil Hydrochloride Tablets

Approval Number: 国药准字H20254129
Registration: May 13, 2025

Pranoprofen Eye Drops

Approval Number: 国药准字H20254154
Registration: May 13, 2025

Ketorolac Trometamol Injection

Approval Number: 国药准字H20254156
Registration: May 13, 2025

Ritonavir Tablets

Approval Number: 国药准字H20254135
Registration: May 13, 2025

Lidocaine Cataplasms

Approval Number: 国药准字H20254079
Registration: May 13, 2025

Ceftazidime for Injection and Sodium Chloride Injection

Approval Number: 国药准字H20254122
Registration: May 13, 2025

Acetylcysteine Effervescent Tablets

Approval Number: 国药准字H20254174
Registration: May 13, 2025

Multiple Electrolytes, Sodium Acetate and Glucose Injection

Approval Number: 国药准字H20254089
Registration: May 13, 2025

Duloxetine Hydrochloride Enteric Capsules

Approval Number: 国药准字H20254132
Registration: May 13, 2025

Carbazochrome Sodium Sulfonate Injection

Approval Number: 国药准字H20254081
Registration: May 13, 2025

Ceftizoxime Sodium for Injection

Approval Number: 国药准字H20254071
Registration: May 13, 2025

Sodium Acetate Ringer’s and Glucose Injection

Approval Number: 国药准字H20254066
Registration: May 13, 2025

Acetylcysteine Injection

Approval Number: 国药准字HJ20250055
Registration: May 13, 2025

Anrikefon Injection

Approval Number: 国药准字H20250014
Registration: May 13, 2025

Iopromide Injection

Approval Number: 国药准字H20254085
Registration: May 13, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.